Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp.
-1.77%148.620.7%$2744.26m
MDTMedtronic Plc
1.01%113.510.6%$524.42m
ABTAbbott Laboratories
0.41%86.320.8%$368.07m
TMOThermo Fisher Scientific, Inc.
0.32%320.391.0%$366.91m
BDXBecton, Dickinson & Co.
1.25%268.751.1%$317.15m
ISRGIntuitive Surgical, Inc.
-0.23%579.652.4%$316.13m
EWEdwards Lifesciences Corp.
0.87%232.711.2%$297.79m
SYKStryker Corp.
1.52%202.811.3%$268.90m
BSXBoston Scientific Corp.
0.90%45.071.1%$262.68m
DXCMDexCom, Inc.
0.91%203.838.3%$205.97m
BAXBaxter International, Inc.
0.54%83.961.8%$191.33m
MTDMettler-Toledo International, Inc.
-0.77%769.445.4%$164.59m
ALGNAlign Technology, Inc.
-0.87%266.066.4%$153.69m
NVSTEnvista Holdings Corp.
-0.95%28.240.0%$150.30m
PODDInsulet Corp.
1.37%175.656.7%$150.15m

Company Profile

Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. Its drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.